Stay updated on Suprachoroidal CLS-AX Safety in AMD Clinical Trial
Sign up to get notified when there's something new on the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page.

Latest updates to the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe updates appear to be minor UI/layout adjustments with no impact on core study information such as eligibility criteria, primary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check39 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference4%

- Check46 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check60 days agoChange DetectedUpdated to Revision v3.0.2 (from v3.0.1); the non-critical 'Back to Top' element was removed; no other substantive changes detected.SummaryDifference0.2%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.2%

- Check75 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several key medical topics and terms related to aflibercept and macular degeneration have been removed.SummaryDifference3%

Stay in the know with updates to Suprachoroidal CLS-AX Safety in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Suprachoroidal CLS-AX Safety in AMD Clinical Trial page.